Bone Biologics Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

NEW YORK, Sept. 16, 2013 /PRNewswire/ -- Bone Biologics today announced its September 12th RetailInvestorConferences.com presentation is now available for on-demand viewing.  

Bone Biologics's presentation will be available 24/7 for 90 days. Investors may download shareholder materials from the "virtual trade booth" for the next three weeks.

LINK:    www.retailinvestorconferences.com > click on the red "register/ watch event now" button

About Bone Biologics:

Bone Biologics was founded by University of California professors in collaboration with an Osaka University professor and a USC Surgeon in 2004.  Bone Biologics is a privately-held company with proprietary, patented technology that has been clinically proven in non-human primate models to facilitate bone growth. The company is currently focused on bone regeneration in spinal fusion using its recombinant human protein, known as UCB-1 (or Nell-1). UCB-1 is an osteoinductive orthobiologic: a recombinant protein that provides control over bone regeneration. This patent protected technology has been exclusively licensed to Bone Biologics from UCLA.

About RetailInvestorConferences.com:

Since 2010, RetailInvestorConferences.com has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.

SOURCE Bone Biologics